Form 4: Kenvue Executive Receives Substantial Equity Awards

Kenvue's Group President North America, Carlos De Jesus, was granted 50,842 Restricted Stock Units and 483,870 Stock Options, vesting over three years.

Summary

• Carlos De Jesus, Group President North America of Kenvue Inc. (KVUE), acquired 50,842 Restricted Stock Units (RSUs) and 483,870 Stock Options.
• The transaction date for these equity awards was December 15, 2025.
• The RSUs correspond one-for-one with the company's common stock, with an acquisition price of $0.
• The Stock Options have an exercise price of $17.21 per share, with an acquisition price of $0.
• Both the RSUs and Stock Options will vest in three equal installments on December 1, 2026, December 1, 2027, and December 1, 2028, contingent on continued service.
• The Stock Options have an expiration date of December 14, 2035.
• Following these transactions, Carlos De Jesus beneficially owns 50,842 Restricted Stock Units and 483,870 Stock Options.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The grant of significant equity awards to a key executive is generally viewed positively as it aligns management's interests with long-term shareholder value creation and serves as a retention tool. It does not, however, directly reflect operational or financial performance.

Positives

• The grant of significant equity awards aligns the executive's long-term financial interests with those of Kenvue's shareholders, promoting sustained value creation.
• Equity grants serve as a strong retention mechanism for key management personnel, ensuring continuity in leadership.
• The establishment of a Rule 10b5-1 plan demonstrates a pre-planned approach to future equity transactions, reducing concerns about opportunistic insider trading.

Negatives

• The awards are subject to a multi-year vesting schedule, meaning the executive does not have immediate full ownership or liquidity.
• The value realized from these awards is dependent on Kenvue's future stock price performance, introducing market risk.
• The exercise price of $17.21 for the stock options means the stock price must exceed this value for the options to be 'in the money' and provide a profit upon exercise.

Risks

• The value of the Restricted Stock Units and Stock Options is subject to the volatility of Kenvue's common stock price.
• Forfeiture of unvested awards may occur if the reporting person's service to the company terminates before the vesting dates.
• Future dilution of existing shares could occur upon the exercise of stock options or conversion of RSUs into common stock.

Future Outlook

The equity awards are designed to incentivize long-term performance and retention of a key executive, with vesting scheduled over the next three years, aligning the executive's future compensation with Kenvue's stock performance through 2028 and beyond for the options.

Industry Context

The granting of Restricted Stock Units and Stock Options is a standard practice in executive compensation across publicly traded companies, particularly in the consumer health sector, to attract, retain, and motivate senior leadership by linking their compensation to shareholder value creation.

Comparison to Industry Standards

• The use of a combination of Restricted Stock Units and Stock Options for executive compensation is a common practice, comparable to compensation structures seen in other large consumer goods and healthcare companies like Procter & Gamble, Johnson & Johnson (from which Kenvue spun off), and Colgate-Palmolive.
• The multi-year vesting schedule (three equal installments) is typical for long-term incentive plans, ensuring sustained commitment from the executive.
• The establishment of a Rule 10b5-1 plan is a widely adopted corporate governance best practice for insiders to manage their equity holdings in a compliant and transparent manner, similar to practices at most S&P 500 companies.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity grants align the executive's incentives with shareholder value, potentially leading to better long-term performance. However, future exercise/conversion could lead to minor dilution.
• Employees: May view the executive's long-term commitment as a positive sign of company stability and future prospects.
• Management: The awards serve as a significant component of executive compensation, motivating performance and ensuring retention.

Next Steps

• The Restricted Stock Units and Stock Options will vest in three equal installments on December 1, 2026, December 1, 2027, and December 1, 2028, subject to continued service.
• The executive may exercise the vested stock options at any time before their expiration on December 14, 2035.

Key Dates

Keywords

Kenvue, KVUE, Insider Transaction, Equity Grant, Restricted Stock Units, Stock Options, Executive Compensation, Carlos De Jesus, 10b5-1 Plan, Vesting